SEPTInvestingStart Free

AKTX SCHEDULE 13G/A: SEC filing

MMCAP International Inc. SPC and MM Asset Management Inc.

Filed with the SEC on · accession 0000912282-26-001483

AKTX filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. MMCAP International Inc. SPC and MM Asset Management Inc. filed an amended Schedule 13G reporting beneficial ownership of 11,427 American Depositary Shares of Akari Therapeutics Plc, representing approximately 0.6% of the class on a partially-diluted basis. The stock moved +4.5% by the first close after the filing.

Summary of the filing

MMCAP International Inc. SPC and MM Asset Management Inc. filed an amended Schedule 13G reporting beneficial ownership of 11,427 American Depositary Shares of Akari Therapeutics Plc, representing approximately 0.6% of the class on a partially-diluted basis. The filing is a passive investment disclosure with no stated intent to influence control.

For details, click here →

Key details

American Depositary Shares beneficially owned$11K
Percent of class owned (partially-diluted basis)PCT 1
Issuer/subject companyAkari Therapeutics Plc
Reporting person / beneficial ownerMMCAP International Inc. SPC
Reporting person / joint filerMM Asset Management Inc.
Director, mmcap international inc. spcUlla Vestergaard
President, mm asset management inc.Hillel Meltz

How AKTX stock reacted

Close before

$6.51

Nov 12, 2026

First close after

+4.45%

$6.80

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for AKTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AKTX?

Click here

Frequently asked questions

What did AKTX file with the SEC on Nov 13, 2026?

AKTX filed a SCHEDULE 13G/A (SEC filing). MMCAP International Inc. SPC and MM Asset Management Inc. filed an amended Schedule 13G reporting beneficial ownership of 11,427 American Depositary Shares of Akari Therapeutics Plc, representing approximately 0.6% of the class on a partially-diluted basis. The filing is a passive investment disclosure with no stated intent to influence control.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did AKTX stock react to this filing?

AKTX closed at $6.51 before the filing and $6.80 on Nov 13, 2026 (+4.45%).

Other AKTX SEC filings

Get alerts when AKTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days
AKTX overviewAKTX analysisAKTX newsLatest SEC filings